About | Free Trial

Last Update

2016-01-26T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong John Barr?

Mr. John Barr R. Jr.

Chief Executive Officer

Surgical Specialties Corporation

HQ Phone: (781) 602-6777

Surgical Specialties Corporation

50 Braintree Hill Office Park, Suite 101

Braintree, Massachusetts 02184

United States

Company Description

Surgical Specialties Corporation is a wholly-owned subsidiary of Angiotech Pharmaceuticals, which was acquired during the acquisition of American Medical Instruments Holdings, Inc. in March 2006. Based in Reading, Pennsylvania, Surgical Specialties Corpor... more

Find other employees at this company (184)

Background Information

Affiliations

Board Member
EarlySense LTD

Board Member
Transfusion Technologies and Learning Solutions

President and Chief Executive Officer
Bausch & Lomb Incorporated

President and Member of the Board of Directors
Haemonetics Corporation

Education

B.S.
Bioengineering
University of Pennsylvania

M.B.A.

J.L. Kellogg Graduate School of Management at Northwestern University

MBA

Kellogg School of Management at Northwestern University

Master's Degree
management
J.L. Kellogg Graduate School of Management

Master’s Degree
management
J.L. Kellogg Graduate School of Management

master's degree
Accounting and Economics
J. L. Kellogg Graduate School of Management-Northwestern University

undergraduate degree
Biomedical Engineering
University of Pennsylvania

Web References (196 Total References)


Healthcare Venture Capital | Board Of Directors | EarlySense

www.earlysense.com [cached]

John R. Barr

...
Mr. Barr earned his experience serving at some innovative and successful medical device companies. He was most recently Executive Vice President and President of Global Surgical at Bausch & Lomb Holdings Incorporated until the acquisition of Bausch and Lomb by Valeant Pharmaceuticals in 2013. Prior to Bausch and Lomb, Barr was the CEO of AGA Medical, pioneer and leader in minimally invasive devices to repair structural heart defects and other vascular defects. Mr. Barr led a IPO for the Company in 2009 and the business was sold to St. Jude Medical in 2010.
Mr. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University where he earned his Master's degree in finance, accounting and economics. He earned his undergraduate degree in bioengineering from the University of Pennsylvania.


John R. Barr Chief ...

angio.com [cached]

John R. Barr Chief Executive Officer READ MORE READ LESS

Chief Executive Officer, Mr. John R. Barr, has over 30 years of experience in the medical device industry. Prior to joining Surgical Specialties Corporation, Mr. Barr served as the Executive Vice President and President of Global Surgical at Bausch & Lomb (until the company's 2013 acquisition by Valeant Pharmaceuticals). From 2005 to 2011 Mr. Barr rose from the role of Chief Operating Officer to Chief Executive Officer of AGA Medical Corporation, which went public in 2009. As Chief Executive Officer of V.I. Technologies, from 1997-2005, he led the company's 2008 IPO. Mr. Barr is also a past President and Member of the Board of Directors of Haemonetics Corporation and began his career at Baxter Healthcare Corporation.
Mr. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University where he earned his Master's degree in finance, accounting and economics. He earned his undergraduate degree in bioengineering from the University of Pennsylvania.


John R. Barr Chief ...

angio.com [cached]

John R. Barr Chief Executive Officer READ MORE READ LESS

Chief Executive Officer, Mr. John R. Barr, has over 30 years of experience in the medical device industry. Prior to joining Surgical Specialties Corporation, Mr. Barr served as the Executive Vice President and President of Global Surgical at Bausch & Lomb (until the company's 2013 acquisition by Valeant Pharmaceuticals). From 2005 to 2011 Mr. Barr rose from the role of Chief Operating Officer to Chief Executive Officer of AGA Medical Corporation, which went public in 2009. As Chief Executive Officer of V.I. Technologies, from 1997-2005, he led the company's 2008 IPO. Mr. Barr is also a past President and Member of the Board of Directors of Haemonetics Corporation and began his career at Baxter Healthcare Corporation.
Mr. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University where he earned his Master's degree in finance, accounting and economics. He earned his undergraduate degree in bioengineering from the University of Pennsylvania.


John R. Barr Chief ...

www.manan.com [cached]

John R. Barr Chief Executive Officer READ MORE READ LESS

Chief Executive Officer, Mr. John R. Barr, has over 30 years of experience in the medical device industry. Prior to joining Surgical Specialties Corporation, Mr. Barr served as the Executive Vice President and President of Global Surgical at Bausch & Lomb (until the company's 2013 acquisition by Valeant Pharmaceuticals). From 2005 to 2011 Mr. Barr rose from the role of Chief Operating Officer to Chief Executive Officer of AGA Medical Corporation, which went public in 2009. As Chief Executive Officer of V.I. Technologies, from 1997-2005, he led the company's 2008 IPO. Mr. Barr is also a past President and Member of the Board of Directors of Haemonetics Corporation and began his career at Baxter Healthcare Corporation.
Mr. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University where he earned his Master's degree in finance, accounting and economics. He earned his undergraduate degree in bioengineering from the University of Pennsylvania.


John R. Barr Chief ...

www.manan.com [cached]

John R. Barr Chief Executive Officer READ MORE READ LESS

Chief Executive Officer, Mr. John R. Barr, has over 30 years of experience in the medical device industry. Prior to joining Surgical Specialties Corporation, Mr. Barr served as the Executive Vice President and President of Global Surgical at Bausch & Lomb (until the company's 2013 acquisition by Valeant Pharmaceuticals). From 2005 to 2011 Mr. Barr rose from the role of Chief Operating Officer to Chief Executive Officer of AGA Medical Corporation, which went public in 2009. As Chief Executive Officer of V.I. Technologies, from 1997-2005, he led the company's 2008 IPO. Mr. Barr is also a past President and Member of the Board of Directors of Haemonetics Corporation and began his career at Baxter Healthcare Corporation.
Mr. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University where he earned his Master's degree in finance, accounting and economics. He earned his undergraduate degree in bioengineering from the University of Pennsylvania.

Similar Profiles

Other People with this Name

Other people with the name Barr

Adrienne Barr

Charlene Barr
Mennonite Central Committee

Matt Barr
MasterCard

Andrew Barr
Hamlin Scientific

Mark Barr
Skagit Pediatrics LLP

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory